Prevenar 13 Vaccination in India

Prevenar 13 is a PCV vaccine by Pfizer. 

Product type:

Pneumococcal conjugate vaccine (Serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F)

Disease prevented:

Pneumonia and invasive disease caused by S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F (including sepsis, meningitis, bacteraemia, pneumonia) and acute otitis media in infants and children

Manufacturing company:

Pfizer

Country of Origin:

USA

Recommended for:

For children above 6 weeks of age, for adults and for seniors.

Directions for use:

To be administered intramuscularly by a trained healthcare professional. Kindly do not self-administer.

FAQs about Prevenar 13 vaccination in India

What are the benefits of Prevenar 13 vaccination?

Prevenar 13 is a pneumococcal conjugated vaccine indicated for the prevention of Pneumonia and invasive disease caused by S. pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F and 23F (including sepsis, meningitis, bacteraemia, pneumonia) and acute otitis media in infants and children.

What is the recommended dosing schedule for Prevenar 13 vaccination?

• Infants aged 6 weeks-6 months

         Three-dose primary series

1. The recommended immunisation series consists of four doses, each of 0.5 ml
2. The primary infant series consists of three doses, with the first dose usually given at 2 months of age and with an interval of at least 1 month between doses
3. The first dose may be given as early as six weeks of age. The fourth (booster) dose is recommended between 11 and 15 months of age

         Two-dose primary series alternatively, 

1. When Prevenar 13 is given as part of a routine infant immunisation programme, a series consisting of three doses, each of 0.5 ml, may be given
2. The first dose may be administered from the age of 2 months, with a second dose 2 months later
3. The third (booster) dose is recommended between 11 and 15 months of age

• Unvaccinated infants and children ≥ 7 months of age Infants aged 7-11 months

1. Two doses, each of 0.5 ml, with an interval of at least 1 month between doses. A third dose is recommended in the second year of life
2. Children aged 12-23 months Two doses, each of 0.5 ml, with an interval of at least 2 months between doses
3. Children and adolescents aged 2-17 years One single dose of 0.5 ml

• Children and adolescents 5–17 years

1. Children 5 to 17 years of age may receive a single dose of Prevenar 13 if they have been previously vaccinated with one or more doses of Prevenar
2. This dose of Prevenar 13 should be administered at least 8 weeks after the final dose of Prevenar (7-valent)

• Adults ≥18 years of age, and the elderly

1. One single dose. The need for revaccination with a subsequent dose of Prevenar 13 has not been established
2. Regardless of prior pneumococcal vaccination status, if the use of 23-valent pneumococcal polysaccharide vaccine is considered appropriate, Prevenar 13 should be given first

How is Prevenar 13 vaccine administered?

Prevenar 13 is administered as an intramuscular injection in the deltoid region of the arm or anterolateral region of the thigh by a trained healthcare professional. Do not self-inject the vaccine. 

Are there any side effects associated with Prevenar 13 vaccination?

Prevenar 13 is generally well tolerated. General side-effects include mild pain and redness at injection site which is transient and self resolves within a few days. Serious side effects are very rare.   

Are there any contraindications for Prevenar 13 vaccination?

Prevenar 13 is contraindicated in cases which have had allergic reaction to any previous dose of the vaccine or to any component of the vaccine.

Is there any specific preparation needed before getting the Prevenar 13 vaccination?

Prevenar 13 vaccination can be taken at any time of the day, and there are no specific requirements such as fasting or post-meal administration.

What precautions should be observed after receiving the Prevenar 13 vaccine?

Prevenar 13 is generally well tolerated and does not disrupt your daily activities, including food, travel and medication use. However, if you have any concerns or specific health conditions, it's advisable to discuss them with your healthcare provider before vaccination. 

Where can I get more information about Prevenar 13 vaccine in India?

INVC vaccine experts are here to provide you with up-to-date guideline-based information to help you make an informed decision about Prevenar 13 vaccination. However, if you have any specific health conditions or a unique medical history, we also advise you to consult with your healthcare provider for personalized guidance.

Where can I book an appointment forPrevenar 13 vaccination in India?

You can schedule an appointment with INVC to receive the Prevenar 13 vaccine at your nearest centre or at the convenience of your home in India.

Your trusted Vaccination Experts are here to help you.